These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 176030)

  • 1. Preliminary pharmacological studies with 1,6-dimesyl-2,3-4,5-dianhydro-L-iditol in patients with cancer.
    Csetényi J; Bihari V; Számel SI; Horváth IP; Eckhardt S
    Eur J Cancer (1965); 1975 Sep; 11(9):675-6. PubMed ID: 176030
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of the antitumor action of 1,6-di-o-methane-sulfonide-2,3-4,5-dianhydro-1-iditol].
    Lapis K
    Vopr Onkol; 1976; 22(6):61-71. PubMed ID: 184592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of dibromodulcitol (NSC-104800).
    Andrews NC; Weiss AJ; Ansfield FJ; Rochlin DB; Mason JH
    Cancer Chemother Rep; 1971 Feb; 55(1):61-5. PubMed ID: 5121653
    [No Abstract]   [Full Text] [Related]  

  • 4. Initial clinical trial of dibromodulcitol (NSC-104800) in patients with advanced cancer.
    Keyes JW; Selawry OS; Hansen HH
    Cancer Chemother Rep; 1971 Dec; 55(5):583-9. PubMed ID: 5003621
    [No Abstract]   [Full Text] [Related]  

  • 5. Regio- and stereoselective cyclizations of dianhydro sugar alcohols catalyzed by a chiral (salen)Co(III) complex.
    Satoh T; Imai T; Umeda S; Tsuda K; Hashimoto H; Kakuchi T
    Carbohydr Res; 2005 Dec; 340(17):2677-81. PubMed ID: 16182265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yoshi 864 (1-propanol, 3,3'-iminodi-, dimethanesulfonate [ester], hydrochloride): a phase II study in solid tumors.
    Altman SJ; Metter GE; Nealon TF; Weiss AJ; Ramirez G; Madden RE; Fletcher WS; Strawitz JG; Multhauf PM
    Cancer Treat Rep; 1978 Mar; 62(3):389-95. PubMed ID: 206359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anhydrides of polyhydric alcohols; 1 : 4-3 : 6-dianhydro-d- and -1-iditol.
    WIGGINS LF
    J Chem Soc; 1947 Oct; ():1403-5. PubMed ID: 20272141
    [No Abstract]   [Full Text] [Related]  

  • 8. 1,6-Di-O-methanesulphonyl-2,3-4,5-dianhydro-L-iditol, a new potential antitumour agent. Biological investigations.
    Csányi E; Halász M
    Arzneimittelforschung; 1973 Jul; 23(7):961-7. PubMed ID: 4356189
    [No Abstract]   [Full Text] [Related]  

  • 9. Yoshi 864 (NSC 102627) 1-propanol, 3, 3'-iminodi-dimethanesulfonate (ester) hydrochloride: a phase 1 study.
    Altman SJ; Fletcher WS; Andrews NC; Wilson WL; Pischer T
    Cancer; 1975 Apr; 35(4):1145-7. PubMed ID: 163676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effect of vincristine and alkylating agent No. 864 on rat leukemia in relation to the distribution of drugs and leukemic cells.
    Aoshima M; Sakurai Y
    Gan; 1973 Oct; 64(5):417-25. PubMed ID: 4358729
    [No Abstract]   [Full Text] [Related]  

  • 11. Hexitol anhydrides; 1,4,3,6-dianhydro-L-iditol and the structures of isomannide and isosorbide.
    FLETCHER HG; GOEPP RM
    J Am Chem Soc; 1946 Jun; 68():939-41. PubMed ID: 20985595
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential bis-alkylating agents for cancer chemotherapy. Approaches to the synthesis of 2-sulfonyl-1,4-bis(methanesulfonoxy)butanes.
    Wilbur JM
    J Med Chem; 1978 Nov; 21(11):1168-71. PubMed ID: 214556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of cross-resistance between two alkylating agents: BCNU vs bifunctional galactitol.
    Institóris E; Szikla K; Otvös L; Gál F
    Cancer Chemother Pharmacol; 1989; 24(5):311-3. PubMed ID: 2758560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary observations on the results of treating malignant lymphoma with Lycurim].
    Polubiec A; Kolakowska-Polubiec K; Mariańska B; Perzanowska I
    Acta Haematol Pol; 1977; 8(3):213-9. PubMed ID: 200051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hungarian anticancer drugs (antineoplastics).
    Kerpel-Fronius S
    Ther Hung; 1982; 30(3):110-21. PubMed ID: 6095482
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase I and II studies of cytostatic hexitol derivatives: the role of alkylating metabolites?
    Eckhardt S; Kerpel-Fronius S; Horváth IP; Institoris L
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):783-8. PubMed ID: 3985644
    [No Abstract]   [Full Text] [Related]  

  • 17. Synergistic effects of bis(3-methylsulfonyloxypropyl)-amine toluenesulfonate (864-T) with 6-mercaptopurine and other antitumor agents.
    Imamura H; Ikegami K; Okumoto T
    Gan; 1973 Oct; 64(5):427-31. PubMed ID: 4358730
    [No Abstract]   [Full Text] [Related]  

  • 18. 1,6-anhydro-1(6)-thio-L-iditol and -D-mannitol, and some derivatives thereof.
    Kuszmann J; Sohár P
    Carbohydr Res; 1977 Jun; 56(1):105-15. PubMed ID: 880583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohols of the sugar group; 2,5-anhydro-L-iditol.
    VARGHA L; PUSKAS T; NAGY E
    J Am Chem Soc; 1948 Jan; 70(1):261. PubMed ID: 18918826
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo synchronization and cell kinetics-directed treatment scheduled in human tumor therapy.
    Barranco SC; Townsend CM; Costanzi JJ; Guseman LF
    Prog Clin Biol Res; 1983; 132C():163-70. PubMed ID: 6634770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.